Urinalysis Market Size - By Product (Consumables, Instruments), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), Global Forecast 2023 - 2032

Urinalysis Market Size

Urinalysis Market size was worth USD 3.8 billion in 2022 and is poised to witness 5.2% CAGR from 2023 to 2032, driven by the increasing incidence of urinary tract infections (UTIs) in developing regions along with the surging demand for better diagnostic and treatment techniques.

Urinalysis has emerged widely popular as one of the most effective and safe methods of diagnosis for determining UTIs. According to the American Urological Association, about 40% to 60% of women are likely to develop a UTI at least once in their lifetimes, whereas just 12% of men are expected to suffer from them. Urinalysis constitutes several tests to examine the urine samples to determine the number of white blood cells, red blood cells, and bacteria. The growing focus on lowering the likelihood of serious problems linked with UTI at later stages will also drive the market growth.

The rising development expenses driven by the continuous improvements and automation in urinalysis may restrict the business expansion. The new technical improvements have made way for significant advancements in automated urinalysis leading to increased R&D expenditures and hampered company profitability. The surge in legal and administrative fees incurred during protection of the property rights will further add to the overall cost of progress, limiting the market growth to some extent. 

COVID-19 Impact

Though the COVID-19 pandemic impacted several healthcare operations, the urinalysis market witnessed steady growth. The increased risks of the infected patients with chronic renal illness resulted in the rising demand for regular testing. In order to detect SARS-CoV-2 renal tropism in the affected patients, several guidelines recommended the adoption of urinalysis during hospital admission. Hence, the growing need for urine testing among COVID-19 patients during the pandemic aided the market expansion.
 

Urinalysis Market Trends

The rising prevalence of pregnancy worldwide will surge the need for urinalysis due to the surging requirement for frequent testing to assure safety. According to WHO estimates, 21 million girls aged between 15 -19 in developing countries become pregnant each year. Most healthcare practitioners employ urine sample testing for the screening of germs to signal UTIs at the first prenatal appointment through laboratory urinalysis. The increasing implementation of these tests by several clinicians during routine visits to assess infection risks will add to the industry progress.

Urinalysis Market Analysis

Based on product, the urinalysis market size from the consumables segment is anticipated to grow at 4.6% CAGR from 2023-2032. The growth can be attributed to the rising frequency of regular checkup cycles driven by the growing awareness of the importance of early illness identification.  In addition, the increasing technological improvements have led to the development of creative and user-friendly consumables. The growing acceptance of dipsticks for renal illness, pregnancy, and diabetes detection will also add to the segment expansion.

In terms of application, the urinalysis market from the urinary tract infections (UTI) segment accounted for USD 1.4 billion in revenue in 2022 and is anticipated to record considerable growth through 2032. The high frequency of UTIs worldwide will increase the demand for diagnostic testing. The growing awareness regarding the difficulties associated with untreated UTIs as well as the importance of early identification and treatment has resulted in the rising importance of urine testing. Furthermore, the higher availability and accessibility of early illness diagnosis to reduce the burden of UTI diseases in developed and emerging nations will influence the market trends.

Based on end-use, the urinalysis market from the hospital segment garnered 38.7% revenue share in 2022 and is anticipated to expand at notable CAGR from 2023 to 2032 owing to the growing preference for urinalysis as the initial diagnostic tool to treat a variety of disorders in hospitals. In addition, the presence of innovative technologies, such as automated urine analyzers for precise diagnosis in these facilities as well as qualified staff will foster the segment demand.

North America held 36% share in the urinalysis market in 2022 and is set to reach USD 2.3 billion by 2032. The robust presence of key market players and well-established healthcare systems with advanced healthcare facilities are contributing to the increasing adoption of advanced urinalysis technologies in the region. Furthermore, the high prevalence of chronic kidney diseases and diabetes coupled with the growing emphasis on personalized medicines will positively impact the market share.

Urinalysis Market Share

• Bio-Rad Laboratories, Inc
• Cardinal Health
• ARKRAY Inc.
• ACON Laboratories, Inc.
• Abbott Laboratories
• Sysmex Corporation
• Teco Diagnostics
• Erba Mannheim
• Siemens Healthineers
• Elektronika Kft
• F.Hoffmann-La Roche Ltd.

are some of the leading enterprises operating in the market.
 

Urinalysis Market News

• In September 2022, Sysmex Corp. unveiled its new UF-1500 fully automatic urine particle analyzing tool for urine sediment testing. This new offering assisted the firm in strengthening and expanding its product portfolio while maintaining its market position.
   
• In July 2022, ARKRAY introduced AUTION AI-4510, an innovative automated urine sediment analyzer with built-in capabilities to speed up operations. This is the first sediment system with onboard auto dilution that eliminates waste and ensures greater accuracy.
   

Urinalysis market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market Size, By Product (USD Million)

• Consumables
  • Dipsticks
  • Reagents
  • Disposables
• Instruments
  • Biochemical urine analyzer
  • Automated urine sediment analyzer

Market Size, By Application (USD Million)

• Urinary tract infections [UTI]
• Kidney disease
• Pregnancy
• Diabetes
• Others

Market Size, By End-use (USD Million)

• Clinical laboratories
• Hospitals
• Home healthcare
• Others

The above information is provided for the following regions and countries (USD Million):

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • The Netherlands
  • Denmark
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt